{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T06:24:29Z","timestamp":1780554269427,"version":"3.54.1"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:00:00Z","timestamp":1707523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:00:00Z","timestamp":1707523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["K23HL166961"],"award-info":[{"award-number":["K23HL166961"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiol Ther"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s40119-024-00351-y","type":"journal-article","created":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T12:02:13Z","timestamp":1707566533000},"page":"17-37","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Contemporary Management of Cardiomyopathy and Heart Failure in Pregnancy"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5190-4777","authenticated-orcid":false,"given":"Henrietta","family":"Afari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6219-1947","authenticated-orcid":false,"given":"Megan","family":"Sheehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2942-3731","authenticated-orcid":false,"given":"Nosheen","family":"Reza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,10]]},"reference":[{"issue":"9516","key":"351_CR1","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/S0140-6736(06)68397-9","volume":"367","author":"KS Khan","year":"2006","unstructured":"Khan KS, Wojdyla D, Say L, G\u00fclmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet Lond Engl. 2006;367(9516):1066\u201374.","journal-title":"Lancet Lond Engl"},{"issue":"10","key":"351_CR2","doi-asserted-by":"publisher","first-page":"e561","DOI":"10.1542\/neo.20-10-e561","volume":"20","author":"ARY Collier","year":"2019","unstructured":"Collier ARY, Molina RL. Maternal mortality in the United States: updates on trends, causes, and solutions. NeoReviews. 2019;20(10):e561\u201374.","journal-title":"NeoReviews"},{"key":"351_CR3","doi-asserted-by":"crossref","unstructured":"Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women\u20142011 update: a guideline from the American Heart Association. Circulation. 2011;123(11):1243\u201362.","DOI":"10.1161\/CIR.0b013e31820faaf8"},{"key":"351_CR4","doi-asserted-by":"crossref","unstructured":"Heemelaar S, Petrus A, Knight M, van den Akker T. Maternal mortality due to cardiac disease in low- and middle-income countries. Trop Med Int Health. 2020;25(6):673\u201386.","DOI":"10.1111\/tmi.13386"},{"key":"351_CR5","doi-asserted-by":"crossref","unstructured":"Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomstrom-Lundqvist C, Cifkova R, De Bonis M, et al. 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy. Kardiol Pol. 2019;77(3):245\u2013326.","DOI":"10.5603\/KP.2019.0049"},{"issue":"6","key":"351_CR6","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1097\/AOG.0b013e3181fdfb11","volume":"116","author":"CJ Berg","year":"2010","unstructured":"Berg CJ, Callaghan WM, Syverson C, Henderson Z. Pregnancy-related mortality in the United States, 1998 to 2005. Obstet Gynecol. 2010;116(6):1302\u20139.","journal-title":"Obstet Gynecol"},{"issue":"8","key":"351_CR7","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/eurjhf\/hfq120","volume":"12","author":"K Sliwa","year":"2010","unstructured":"Sliwa K, Hilfiker-Kleiner D, Petrie MC, Mebazaa A, Pieske B, Buchmann E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail. 2010;12(8):767\u201378.","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"351_CR8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jacc.2019.11.014","volume":"75","author":"MB Davis","year":"2020","unstructured":"Davis MB, Arany Z, McNamara DM, Goland S, Elkayam U. Peripartum cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75(2):207\u201321.","journal-title":"J Am Coll Cardiol"},{"key":"351_CR9","doi-asserted-by":"crossref","unstructured":"McNamara DM, Elkayam U, Alharethi R, Damp J, Hsich E, Ewald G, et al. Clinical outcomes for peripartum cardiomyopathy in North America: results of the IPAC study (Investigations of Pregnancy-Associated Cardiomyopathy). J Am Coll Cardiol. 2015;66(8):905\u201314.","DOI":"10.1016\/j.jacc.2015.06.1309"},{"issue":"9","key":"351_CR10","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.jchf.2023.03.012","volume":"11","author":"N Reza","year":"2023","unstructured":"Reza N, Packard E, Goli R, Chowns JL, Owens AT, Arany Z, et al. Clinical predictors of referral for and yield of genetic testing in peripartum cardiomyopathy. JACC Heart Fail. 2023;11(9):1278\u201380.","journal-title":"JACC Heart Fail"},{"issue":"13","key":"351_CR11","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1161\/CIRCULATIONAHA.109.901496","volume":"121","author":"K Sliwa","year":"2010","unstructured":"Sliwa K, Blauwet L, Tibazarwa K, Libhaber E, Smedema JP, Becker A, et al. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation. 2010;121(13):1465\u201373.","journal-title":"Circulation"},{"issue":"4","key":"351_CR12","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s00395-013-0366-9","volume":"108","author":"A Haghikia","year":"2013","unstructured":"Haghikia A, Podewski E, Libhaber E, Labidi S, Fischer D, Roentgen P, et al. Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy. Basic Res Cardiol. 2013;108(4):366.","journal-title":"Basic Res Cardiol"},{"issue":"35","key":"351_CR13","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1093\/eurheartj\/ehx355","volume":"38","author":"D Hilfiker-Kleiner","year":"2017","unstructured":"Hilfiker-Kleiner D, Haghikia A, Berliner D, Vogel-Claussen J, Schwab J, Franke A, et al. Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study. Eur Heart J. 2017;38(35):2671\u20139.","journal-title":"Eur Heart J"},{"key":"351_CR14","unstructured":"Writing Committee Members, Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, et al. 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128(16):e240-327."},{"issue":"5","key":"351_CR15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1053\/j.semperi.2014.04.021","volume":"38","author":"J Lewey","year":"2014","unstructured":"Lewey J, Haythe J. Cardiomyopathy in pregnancy. Semin Perinatol. 2014;38(5):309\u201317.","journal-title":"Semin Perinatol"},{"issue":"1","key":"351_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jacc.2009.08.036","volume":"55","author":"J Grewal","year":"2009","unstructured":"Grewal J, Siu SC, Ross HJ, Mason J, Balint OH, Sermer M, et al. Pregnancy outcomes in women with dilated cardiomyopathy. J Am Coll Cardiol. 2009;55(1):45\u201352.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"351_CR17","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jacc.2011.04.014","volume":"58","author":"K Stergiopoulos","year":"2011","unstructured":"Stergiopoulos K, Shiang E, Bench T. Pregnancy in patients with pre-existing cardiomyopathies. J Am Coll Cardiol. 2011;58(4):337\u201350.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"351_CR18","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/CRD.0000000000000394","volume":"30","author":"A Lloji","year":"2022","unstructured":"Lloji A, Panza JA. The challenge of pregnancy in women with hypertrophic cardiomyopathy. Cardiol Rev. 2022;30(5):258\u201362.","journal-title":"Cardiol Rev"},{"issue":"10","key":"351_CR19","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1016\/S0735-1097(02)02495-6","volume":"40","author":"C Autore","year":"2002","unstructured":"Autore C, Conte MR, Piccininno M, Bernab\u00f2 P, Bonfiglio G, Bruzzi P, et al. Risk associated with pregnancy in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002;40(10):1864\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"359","key":"351_CR20","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ijcard.2022.04.034","volume":"15","author":"M Moolla","year":"2022","unstructured":"Moolla M, Mathew A, John K, Yogasundaram H, Alhumaid W, Campbell S, et al. Outcomes of pregnancy in women with hypertrophic cardiomyopathy: a systematic review. Int J Cardiol. 2022;15(359):54\u201360.","journal-title":"Int J Cardiol"},{"issue":"8","key":"351_CR21","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1161\/CIR.0000000000000458","volume":"135","author":"MM Canobbio","year":"2017","unstructured":"Canobbio MM, Warnes CA, Aboulhosn J, Connolly HM, Khanna A, Koos BJ, et al. Management of pregnancy in patients with complex congenital heart disease: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2017;135(8):e50-87.","journal-title":"Circulation"},{"issue":"18","key":"351_CR22","first-page":"e895","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895-1032.","journal-title":"Circulation"},{"issue":"8","key":"351_CR23","doi-asserted-by":"publisher","first-page":"E60","DOI":"10.1002\/clc.20391","volume":"32","author":"AB Hameed","year":"2009","unstructured":"Hameed AB, Chan K, Ghamsary M, Elkayam U. Longitudinal changes in the B-type natriuretic peptide levels in normal pregnancy and postpartum. Clin Cardiol. 2009;32(8):E60-62.","journal-title":"Clin Cardiol"},{"issue":"15","key":"351_CR24","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.jacc.2010.02.076","volume":"56","author":"D Tanous","year":"2010","unstructured":"Tanous D, Siu SC, Mason J, Greutmann M, Wald RM, Parker JD, et al. B-type natriuretic peptide in pregnant women with heart disease. J Am Coll Cardiol. 2010;56(15):1247\u201353.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"351_CR25","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ajog.2004.12.006","volume":"193","author":"JL Resnik","year":"2005","unstructured":"Resnik JL, Hong C, Resnik R, Kazanegra R, Beede J, Bhalla V, et al. Evaluation of B-type natriuretic peptide (BNP) levels in normal and preeclamptic women. Am J Obstet Gynecol. 2005;193(2):450\u20134.","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"351_CR26","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1093\/eurheartj\/eht526","volume":"35","author":"MAM Kampman","year":"2014","unstructured":"Kampman MAM, Balci A, van Veldhuisen DJ, van Dijk APJ, Roos-Hesselink JW, Sollie-Szarynska KM, et al. N-terminal pro-B-type natriuretic peptide predicts cardiovascular complications in pregnant women with congenital heart disease. Eur Heart J. 2014;35(11):708\u201315.","journal-title":"Eur Heart J"},{"issue":"8","key":"351_CR27","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.121.009018","volume":"15","author":"SA Chang","year":"2022","unstructured":"Chang SA, Khakh P, Janzen M, Lee T, Kiess M, Rychel V, et al. Trending cardiac biomarkers during pregnancy in women with cardiovascular disease. Circ Heart Fail. 2022;15(8): e009018.","journal-title":"Circ Heart Fail"},{"issue":"7","key":"351_CR28","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1515\/cclm-2022-1285","volume":"61","author":"A Clerico","year":"2023","unstructured":"Clerico A, Zaninotto M, Aimo A, Cardinale DM, Dittadi R, Sandri MT, et al. Variability of cardiac troponin levels in normal subjects and in patients with cardiovascular diseases: analytical considerations and clinical relevance. Clin Chem Lab Med. 2023;61(7):1209\u201329.","journal-title":"Clin Chem Lab Med"},{"issue":"20","key":"351_CR29","doi-asserted-by":"publisher","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","volume":"138","author":"K Thygesen","year":"2018","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal definition of myocardial infarction (2018). Circulation. 2018;138(20):e618\u201351.","journal-title":"Circulation"},{"issue":"2","key":"351_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0247946","volume":"16","author":"S Dockree","year":"2021","unstructured":"Dockree S, Brook J, Shine B, James T, Green L, Vatish M. Cardiac-specific troponins in uncomplicated pregnancy and pre-eclampsia: A systematic review. PLoS ONE. 2021;16(2): e0247946.","journal-title":"PLoS ONE"},{"issue":"2","key":"351_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2020-001293","volume":"7","author":"E Furen\u00e4s","year":"2020","unstructured":"Furen\u00e4s E, Eriksson P, Wennerholm UB, Dellborg M. Pregnancy in a healthy population: dynamics of NTproBNP and hs-cTroponin T. Open Heart. 2020;7(2): e001293.","journal-title":"Open Heart"},{"key":"351_CR32","doi-asserted-by":"crossref","unstructured":"Perrone MA, Zaninotto M, Masotti S, Musetti V, Padoan A, Prontera C, et al. The combined measurement of high-sensitivity cardiac troponins and natriuretic peptides: a useful tool for clinicians? J Cardiovasc Med (Hagerstown). 2020;21(12):953\u201363.","DOI":"10.2459\/JCM.0000000000001022"},{"issue":"16","key":"351_CR33","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1093\/eurheartj\/ehq509","volume":"33","author":"K Thygesen","year":"2012","unstructured":"Thygesen K, Mair J, Mueller C, Huber K, Weber M, Plebani M, et al. Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Eur Heart J. 2012;33(16):2001\u20136.","journal-title":"Eur Heart J"},{"key":"351_CR34","doi-asserted-by":"crossref","unstructured":"Silversides CK, Grewal J, Mason J, Sermer M, Kiess M, Rychel V, et al. Pregnancy outcomes in women with heart disease: the CARPREG II study. J Am Coll Cardiol. 2018;71(21):2419\u201330.","DOI":"10.1016\/j.jacc.2018.02.076"},{"issue":"5","key":"351_CR35","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1161\/hc3001.093437","volume":"104","author":"SC Siu","year":"2001","unstructured":"Siu SC, Sermer M, Colman JM, Alvarez AN, Mercier LA, Morton BC, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001;104(5):515\u201321.","journal-title":"Circulation"},{"issue":"10","key":"351_CR36","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1136\/hrt.2006.095240","volume":"92","author":"S Thorne","year":"2006","unstructured":"Thorne S, MacGregor A, Nelson-Piercy C. Risks of contraception and pregnancy in heart disease. Heart Br Card Soc. 2006;92(10):1520\u20135.","journal-title":"Heart Br Card Soc"},{"issue":"5","key":"351_CR37","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/ejhf.501","volume":"18","author":"IM van Hagen","year":"2016","unstructured":"van Hagen IM, Boersma E, Johnson MR, Thorne SA, Parsonage WA, Escribano Sub\u00edas P, et al. Global cardiac risk assessment in the registry of pregnancy and cardiac disease: results of a registry from the European Society of Cardiology. Eur J Heart Fail. 2016;18(5):523\u201333.","journal-title":"Eur J Heart Fail"},{"issue":"17","key":"351_CR38","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1093\/eurheartj\/ehq200","volume":"31","author":"W Drenthen","year":"2010","unstructured":"Drenthen W, Boersma E, Balci A, Moons P, Roos-Hesselink JW, Mulder BJM, et al. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J. 2010;31(17):2124\u201332.","journal-title":"Eur Heart J"},{"issue":"5","key":"351_CR39","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.120.008223","volume":"14","author":"EM DeFilippis","year":"2021","unstructured":"DeFilippis EM, Haythe JH, Walsh MN, Kittleson MM. Intersection of heart failure and pregnancy: beyond peripartum cardiomyopathy. Circ Heart Fail. 2021;14(5): e008223.","journal-title":"Circ Heart Fail"},{"key":"351_CR40","unstructured":"Power to Decide. One Key Question online. Available from: https:\/\/powertodecide.org\/one-key-question. Accessed 27 oct 2023."},{"issue":"23","key":"351_CR41","doi-asserted-by":"publisher","first-page":"e884","DOI":"10.1161\/CIR.0000000000000772","volume":"141","author":"LS Mehta","year":"2020","unstructured":"Mehta LS, Warnes CA, Bradley E, Burton T, Economy K, Mehran R, et al. Cardiovascular considerations in caring for pregnant patients: a scientific statement from the American Heart Association. Circulation. 2020;141(23):e884-903.","journal-title":"Circulation"},{"issue":"234","key":"351_CR42","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ijcard.2017.02.003","volume":"1","author":"M Cauldwell","year":"2017","unstructured":"Cauldwell M, Ghonim S, Uebing A, Swan L, Steer PJ, Gatzoulis M, et al. Preconception counseling, predicting risk and outcomes in women with mWHO 3 and 4 heart disease. Int J Cardiol. 2017;1(234):76\u201380.","journal-title":"Int J Cardiol"},{"key":"351_CR43","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists\u2019 Committee on Adolescent Health Care. Gynecologic considerations for adolescents and young women with cardiac conditions: ACOG Committee Opinion, number 819. Obstet Gynecol. 136(5):e90\u20139.","DOI":"10.1097\/AOG.0000000000004133"},{"key":"351_CR44","doi-asserted-by":"crossref","unstructured":"Committee on Practice Bulletins\u2014Gynecology. ACOG Practice Bulletin no. 206. Use of hormonal contraception in women with coexisting medical conditions. Obstet Gynecol. 2019;133(2):e128\u201350.","DOI":"10.1097\/AOG.0000000000003072"},{"issue":"9","key":"351_CR45","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.jchf.2023.07.009","volume":"11","author":"EM DeFilippis","year":"2023","unstructured":"DeFilippis EM, Bhagra C, Casale J, Ging P, Macera F, Punnoose L, et al. Cardio-obstetrics and heart failure: JACC: heart failure state-of-the-art review. JACC Heart Fail. 2023;11(9):1165\u201380.","journal-title":"JACC Heart Fail"},{"issue":"12","key":"351_CR46","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/nrcardio.2015.172","volume":"12","author":"PG Pieper","year":"2015","unstructured":"Pieper PG. Use of medication for cardiovascular disease during pregnancy. Nat Rev Cardiol. 2015;12(12):718\u201329.","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"351_CR47","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/CRD.0000000000000038","volume":"23","author":"J Garg","year":"2015","unstructured":"Garg J, Palaniswamy C, Lanier GM. Peripartum cardiomyopathy: definition, incidence, etiopathogenesis, diagnosis, and management. Cardiol Rev. 2015;23(2):69\u201378.","journal-title":"Cardiol Rev"},{"key":"351_CR48","doi-asserted-by":"crossref","unstructured":"Tanaka K, Tanaka H, Kamiya C, Katsuragi S, Sawada M, Tsuritani M, et al. Beta-blockers and fetal growth restriction in pregnant women with cardiovascular disease. Circ J. 2016;80(10):2221\u20136.","DOI":"10.1253\/circj.CJ-15-0617"},{"issue":"10","key":"351_CR49","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/S0002-9149(97)00163-X","volume":"79","author":"GY Lip","year":"1997","unstructured":"Lip GY, Beevers M, Churchill D, Shaffer LM, Beevers DG. Effect of atenolol on birth weight. Am J Cardiol. 1997;79(10):1436\u20138.","journal-title":"Am J Cardiol"},{"issue":"1","key":"351_CR50","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/1471-0528.13463","volume":"123","author":"S Shekhar","year":"2016","unstructured":"Shekhar S, Gupta N, Kirubakaran R, Pareek P. Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: a systematic review and meta-analysis. BJOG Int J Obstet Gynaecol. 2016;123(1):40\u20137.","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"4","key":"351_CR51","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1097\/GRF.0000000000000142","volume":"58","author":"ER Newton","year":"2015","unstructured":"Newton ER, Hale TW. Drugs in breast milk. Clin Obstet Gynecol. 2015;58(4):868\u201384.","journal-title":"Clin Obstet Gynecol"},{"issue":"4","key":"351_CR52","first-page":"540","volume":"95","author":"A Hecker","year":"1980","unstructured":"Hecker A, Hasan SH, Neumann F. Disturbances in sexual differentiation of rat foetuses following spironolactone treatment. Acta Endocrinol (Copenh). 1980;95(4):540\u20135.","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"7","key":"351_CR53","first-page":"451","volume":"40","author":"JF Mosley","year":"2015","unstructured":"Mosley JF, Smith L, Everton E, Fellner C. Sodium-glucose linked transporter 2 (SGLT2) inhibitors in the management of type-2 diabetes: a drug class overview. P T Peer-Rev J Formul Manag. 2015;40(7):451\u201362.","journal-title":"P T Peer-Rev J Formul Manag"},{"issue":"8","key":"351_CR54","first-page":"251","volume":"50","author":"DC Cominos","year":"1976","unstructured":"Cominos DC, van der Walt A, van Rooyen AJ. Suppression of postpartum lactation with furosemide. South Afr Med J Suid-Afr Tydskr Vir Geneeskd. 1976;50(8):251\u20132.","journal-title":"South Afr Med J Suid-Afr Tydskr Vir Geneeskd"},{"issue":"4A","key":"351_CR55","doi-asserted-by":"publisher","first-page":"58I","DOI":"10.1016\/S0002-9149(98)00473-1","volume":"82","author":"T Chow","year":"1998","unstructured":"Chow T, Galvin J, McGovern B. Antiarrhythmic drug therapy in pregnancy and lactation. Am J Cardiol. 1998;82(4A):58I-62I.","journal-title":"Am J Cardiol"},{"issue":"1","key":"351_CR56","first-page":"81","volume":"11","author":"A Potondi","year":"1966","unstructured":"Potondi A. Congenital rhabdomyoma of the heart and intrauterine digitalis poisoning. J Forensic Sci. 1966;11(1):81\u20138.","journal-title":"J Forensic Sci"},{"issue":"2","key":"351_CR57","first-page":"448","volume":"40","author":"M Sillesen","year":"2011","unstructured":"Sillesen M, Hjortdal V, Vejlstrup N, S\u00f8rensen K. Pregnancy with prosthetic heart valves\u201430 years\u2019 nationwide experience in Denmark. Eur J Cardio-Thorac Surg. 2011;40(2):448\u201354.","journal-title":"Eur J Cardio-Thorac Surg"},{"issue":"2","key":"351_CR58","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1001\/archinte.160.2.191","volume":"160","author":"WS Chan","year":"2000","unstructured":"Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med. 2000;160(2):191\u20136.","journal-title":"Arch Intern Med"},{"issue":"10","key":"351_CR59","doi-asserted-by":"publisher","first-page":"1248.e1","DOI":"10.1016\/j.cjca.2015.11.005","volume":"32","author":"Z Xu","year":"2016","unstructured":"Xu Z, Fan J, Luo X, Zhang WB, Ma J, Lin YB, et al. Anticoagulation regimens during pregnancy in patients with mechanical heart valves: a systematic review and meta-analysis. Can J Cardiol. 2016;32(10):1248.e1-1248.e9.","journal-title":"Can J Cardiol"},{"issue":"10","key":"351_CR60","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s11936-017-0575-x","volume":"19","author":"AE Fogerty","year":"2017","unstructured":"Fogerty AE. Challenges of anticoagulation therapy in pregnancy. Curr Treat Options Cardiovasc Med. 2017;19(10):76.","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"6","key":"351_CR61","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.thromres.2015.04.001","volume":"135","author":"S De Carolis","year":"2015","unstructured":"De Carolis S, di Pasquo E, Rossi E, Del Sordo G, Buonomo A, Schiavino D, et al. Fondaparinux in pregnancy: could it be a safe option? A review of the literature. Thromb Res. 2015;135(6):1049\u201351.","journal-title":"Thromb Res"},{"issue":"18","key":"351_CR62","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1056\/NEJM200404293501825","volume":"350","author":"CEH Dempfle","year":"2004","unstructured":"Dempfle CEH. Minor transplacental passage of fondaparinux in vivo. N Engl J Med. 2004;350(18):1914\u20135.","journal-title":"N Engl J Med"},{"issue":"4","key":"351_CR63","first-page":"651","volume":"116","author":"J Beyer-Westendorf","year":"2016","unstructured":"Beyer-Westendorf J, Michalski F, Tittl L, Middeldorp S, Cohen H, Abdul Kadir R, et al. Pregnancy outcome in patients exposed to direct oral anticoagulants\u2014and the challenge of event reporting. Thromb Haemost. 2016;116(4):651\u20138.","journal-title":"Thromb Haemost"},{"issue":"43","key":"351_CR64","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1093\/eurheartj\/ehu283","volume":"35","author":"SV Konstantinides","year":"2014","unstructured":"Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Gali\u00e8 N, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;35(43):3033\u201369 (3069a\u20133069k).","journal-title":"Eur Heart J."},{"key":"351_CR65","doi-asserted-by":"crossref","unstructured":"Boul\u00e9 S, Ovart L, Marqui\u00e9 C, Botcherby E, Klug D, Kouakam C, et al. Pregnancy in women with an implantable cardioverter-defibrillator: is it safe? Europace. 2014;16(11):1587\u201394.","DOI":"10.1093\/europace\/euu036"},{"key":"351_CR66","doi-asserted-by":"crossref","unstructured":"Schuler PK, Herrey A, Wade A, Brooks R, Peebles D, Lambiase P, et al. Pregnancy outcome and management of women with an implantable cardioverter defibrillator: a single centre experience. Europace. 2012;14(12):1740\u20135.","DOI":"10.1093\/europace\/eus172"},{"issue":"7","key":"351_CR67","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1161\/CIRCULATIONAHA.112.146530","volume":"127","author":"A Adler","year":"2013","unstructured":"Adler A, Halkin A, Viskin S. Wearable cardioverter-defibrillators. Circulation. 2013;127(7):854\u201360.","journal-title":"Circulation"},{"issue":"3","key":"351_CR68","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1210\/jcem-43-3-668","volume":"43","author":"H Leblanc","year":"1976","unstructured":"Leblanc H, Lachelin GC, Abu-Fadil S, Yen SS. Effects of dopamine infusion on pituitary hormone secretion in humans. J Clin Endocrinol Metab. 1976;43(3):668\u201374.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"351_CR69","first-page":"349","volume":"38","author":"B Stapel","year":"2017","unstructured":"Stapel B, Kohlhaas M, Ricke-Hoch M, Haghikia A, Erschow S, Knuuti J, et al. Low STAT3 expression sensitizes to toxic effects of \u03b2-adrenergic receptor stimulation in peripartum cardiomyopathy. Eur Heart J. 2017;38(5):349\u201361.","journal-title":"Eur Heart J"},{"key":"351_CR70","doi-asserted-by":"crossref","unstructured":"Bauersachs J, Arrigo M, Hilfiker-Kleiner D, Veltmann C, Coats AJS, Crespo-Leiro MG, et al. Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy. Eur J Heart Fail. 2016;18(9):1096\u2013105.","DOI":"10.1002\/ejhf.586"},{"issue":"12","key":"351_CR71","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11936-019-0797-1","volume":"21","author":"S Sharma","year":"2019","unstructured":"Sharma S, Thomas SS. Management of heart failure and cardiogenic shock in pregnancy. Curr Treat Options Cardiovasc Med. 2019;21(12):83.","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"6","key":"351_CR72","first-page":"908","volume":"81","author":"B Carbonne","year":"1993","unstructured":"Carbonne B, Jannet D, Touboul C, Khelifati Y, Milliez J. Nicardipine treatment of hypertension during pregnancy. Obstet Gynecol. 1993;81(6):908\u201314.","journal-title":"Obstet Gynecol"},{"key":"351_CR73","doi-asserted-by":"crossref","unstructured":"Rihal CS, Naidu SS, Givertz MM, Szeto WY, Burke JA, Kapur NK, et al. 2015 SCAI\/ACC\/HFSA\/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care: endorsed by the American Heart Assocation, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; affirmation of value by the Canadian Association of Interventional Cardiology\u2013Association Canadienne de Cardiologie d\u2019intervention. J Am Coll Cardiol. 2015;65(19):e7-26.","DOI":"10.1016\/j.cardfail.2015.03.002"},{"issue":"2","key":"351_CR74","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/10641955.2016.1242606","volume":"36","author":"J Banayan","year":"2017","unstructured":"Banayan J, Rana S, Mueller A, Tung A, Ramadan H, Arany Z, et al. Cardiogenic shock in pregnancy: analysis from the National Inpatient Sample. Hypertens Pregnancy. 2017;36(2):117\u201323.","journal-title":"Hypertens Pregnancy"},{"issue":"2","key":"351_CR75","first-page":"189","volume":"37","author":"TW Willcox","year":"2005","unstructured":"Willcox TW, Stone P, Milsom FP, Connell H. Cardiopulmonary bypass in pregnancy: possible new role for the intra-aortic balloon pump. J Extra Corpor Technol. 2005;37(2):189\u201391.","journal-title":"J Extra Corpor Technol"},{"key":"351_CR76","doi-asserted-by":"crossref","unstructured":"Lin TY, Chiu KM, Shieh JS, Chu SH. Emergency redo mitral valve replacement in a pregnant woman at third trimester: case report and literature review. Circ J. 2008;72(10):1715\u20137.","DOI":"10.1253\/circj.CJ-07-0775"},{"issue":"8","key":"351_CR77","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1097\/00003246-199008000-00020","volume":"18","author":"JN Allen","year":"1990","unstructured":"Allen JN, Wewers MD. Acute myocardial infarction with cardiogenic shock during pregnancy: treatment with intra-aortic balloon counterpulsation. Crit Care Med. 1990;18(8):888\u20139.","journal-title":"Crit Care Med"},{"issue":"2","key":"351_CR78","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.cardfail.2022.09.014","volume":"29","author":"N Tapaskar","year":"2023","unstructured":"Tapaskar N, Tremblay-Gravel M, Khush KK. Contemporary management of cardiogenic shock during pregnancy. J Card Fail. 2023;29(2):193\u2013209.","journal-title":"J Card Fail"},{"issue":"10","key":"351_CR79","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1002\/clc.23249","volume":"42","author":"U Elkayam","year":"2019","unstructured":"Elkayam U, Sch\u00e4fer A, Chieffo A, Lansky A, Hall S, Arany Z, et al. Use of Impella heart pump for management of women with peripartum cardiogenic shock. Clin Cardiol. 2019;42(10):974\u201381.","journal-title":"Clin Cardiol"},{"key":"351_CR80","doi-asserted-by":"crossref","unstructured":"Schroeter MR, Uns\u00f6ld B, Holke K, Schillinger W. Pro-thrombotic condition in a woman with peripartum cardiomyopathy treated with bromocriptine and an Impella LP 2.5 heart pump. Clin Res Cardiol. 2013;102(2):155\u20137.","DOI":"10.1007\/s00392-012-0494-5"},{"issue":"2","key":"351_CR81","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1002\/ehf2.14254","volume":"10","author":"H Golzarian","year":"2023","unstructured":"Golzarian H, Mariam A, Shah SR, Pasley BA, Haq SH, Edgerton AR, et al. Amniotic fluid embolism-induced cardiopulmonary collapse successfully treated with combination VA-ECMO and Impella CP. ESC Heart Fail. 2023;10(2):1440\u20134.","journal-title":"ESC Heart Fail"},{"key":"351_CR82","doi-asserted-by":"publisher","first-page":"2bcr015211958","DOI":"10.1136\/bcr-2015-211958","volume":"2015","author":"N Desai","year":"2015","unstructured":"Desai N, Chaudhry K, Aji J. Impella left ventricular assist device in cardiac arrest after spinal anaesthesia for caesarean section. BMJ Case Rep. 2015;2015:2bcr015211958.","journal-title":"BMJ Case Rep."},{"issue":"1","key":"351_CR83","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1053\/j.semperi.2017.11.005","volume":"42","author":"LD Pacheco","year":"2018","unstructured":"Pacheco LD, Saade GR, Hankins GDV. Extracorporeal membrane oxygenation (ECMO) during pregnancy and postpartum. Semin Perinatol. 2018;42(1):21\u20135.","journal-title":"Semin Perinatol"},{"issue":"4","key":"351_CR84","doi-asserted-by":"publisher","first-page":"S225","DOI":"10.1016\/j.healun.2013.01.571","volume":"32","author":"A Neumann","year":"2013","unstructured":"Neumann A, Hilfiker-Kleiner D, K\u00fchn C, Fegbeutel C, Hilfiker A, Haverich A, et al. Prolactin\u2014a new marker for ECMO-related mortality. J Heart Lung Transplant. 2013;32(4):S225.","journal-title":"J Heart Lung Transplant"},{"issue":"2","key":"351_CR85","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1161\/CIRCHEARTFAILURE.113.000721","volume":"7","author":"RY Loyaga-Rendon","year":"2014","unstructured":"Loyaga-Rendon RY, Pamboukian SV, Tallaj JA, Acharya D, Cantor R, Starling RC, et al. Outcomes of patients with peripartum cardiomyopathy who received mechanical circulatory support. Data from the Interagency Registry for Mechanically Assisted Circulatory Support. Circ Heart Fail. 2014;7(2):300\u20139.","journal-title":"Circ Heart Fail."},{"issue":"5","key":"351_CR86","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1097\/AOG.0000000000005351","volume":"142","author":"LD Pacheco","year":"2023","unstructured":"Pacheco LD, Saad AF, Lick SD, Iturrizaga JC, Saade GR. Care and monitoring of pregnant patients with left ventricular assist devices. Obstet Gynecol. 2023;142(5):1029\u201335.","journal-title":"Obstet Gynecol."},{"key":"351_CR87","doi-asserted-by":"crossref","unstructured":"Rasmusson K, Brunisholz K, Budge D, Horne BD, Alharethi R, Folsom J, et al. Peripartum cardiomyopathy: post-transplant outcomes from the United Network for Organ Sharing Database. J Heart Lung Transplant. 2012;31(2):180\u20136.","DOI":"10.1016\/j.healun.2011.11.018"},{"issue":"3","key":"351_CR88","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.athoracsur.2021.12.059","volume":"114","author":"JH Kwon","year":"2022","unstructured":"Kwon JH, Tedford RJ, Ramu B, Witer LJ, Pope NH, Houston BA, et al. Heart transplantation for peripartum cardiomyopathy: outcomes over 3 decades. Ann Thorac Surg. 2022;114(3):650\u20138.","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"351_CR89","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.healun.2022.10.009","volume":"42","author":"MM Kittleson","year":"2023","unstructured":"Kittleson MM, DeFilippis EM, Bhagra CJ, Casale JP, Cauldwell M, Coscia LA, et al. Reproductive health after thoracic transplantation: an ISHLT expert consensus statement. J Heart Lung Transplant. 2023;42(3):e1-42.","journal-title":"J Heart Lung Transplant"},{"key":"351_CR90","doi-asserted-by":"crossref","unstructured":"Mckay DB, Josephson MA, Armenti VT, August P, Coscia LA, Davis CL, et al. Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation. Am J Transplant. 2005;5(7):1592\u20139.","DOI":"10.1111\/j.1600-6143.2005.00969.x"},{"issue":"4","key":"351_CR91","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1097\/AOG.0b013e3182a5eda9","volume":"122","author":"VA French","year":"2013","unstructured":"French VA, Davis JS, Sayles HS, Wu SS. Contraception and fertility awareness among women with solid organ transplants. Obstet Gynecol. 2013;122(4):809\u201314.","journal-title":"Obstet Gynecol"},{"issue":"14","key":"351_CR92","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/j.jacc.2021.02.033","volume":"77","author":"MB Davis","year":"2021","unstructured":"Davis MB, Arendt K, Bello NA, Brown H, Briller J, Epps K, et al. Team-based care of women with cardiovascular disease from pre-conception through pregnancy and postpartum: JACC focus seminar 1\/5. J Am Coll Cardiol. 2021;77(14):1763\u201377.","journal-title":"J Am Coll Cardiol"},{"key":"351_CR93","doi-asserted-by":"crossref","unstructured":"Committee on Obstetric Practice. ACOG Committee Opinion no. 765: avoidance of nonmedically indicated early-term deliveries and associated neonatal morbidities. Obstet Gynecol. 2019;133(2):e156\u201363.","DOI":"10.1097\/AOG.0000000000003076"},{"key":"351_CR94","doi-asserted-by":"crossref","unstructured":"Liu S, Liston RM, Joseph KS, Heaman M, Sauve R, Kramer MS, et al. Maternal mortality and severe morbidity associated with low-risk planned cesarean delivery versus planned vaginal delivery at term. CMAJ. 2007;176(4):455\u201360.","DOI":"10.1503\/cmaj.060870"},{"key":"351_CR95","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists\u2019 Presidential Task Force on Pregnancy and Heart Disease and Committee on Practice Bulletins\u2014Obstetrics. ACOG Practice Bulletin no. 212: pregnancy and heart disease. Obstet Gynecol. 2019;133(5):e320\u201356.","DOI":"10.1097\/AOG.0000000000003243"},{"issue":"3","key":"351_CR96","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jacbts.2019.03.005","volume":"4","author":"Z Arany","year":"2019","unstructured":"Arany Z, Feldman AM. To breastfeed or not to breastfeed with peripartum cardiomyopathy. JACC Basic Transl Sci. 2019;4(3):301\u20133.","journal-title":"JACC Basic Transl Sci"},{"key":"351_CR97","doi-asserted-by":"crossref","unstructured":"Ritchie HE, Telenius C, Gustaffson E, Webster WS. The effects of nifedipine and ivabradine on the functionality of the early rat embryonic heart. Are these drugs a risk in early human pregnancy? Birth Defects Res. 2019;111(5):281\u20138.","DOI":"10.1002\/bdr2.1457"},{"issue":"2","key":"351_CR98","doi-asserted-by":"publisher","first-page":"112","DOI":"10.15420\/cfr.2018.21.2","volume":"4","author":"L Kearney","year":"2018","unstructured":"Kearney L, Wright P, Fhadil S, Thomas M. Postpartum cardiomyopathy and considerations for breastfeeding. Card Fail Rev. 2018;4(2):112\u20138.","journal-title":"Card Fail Rev"},{"key":"351_CR99","unstructured":"Merck Sharp & Dohme LLC. Verquvo (vericiguat) [prescribing information]. Rahway: Merck Sharp & Dohme LLC; 2023. Available from: https:\/\/www.merckconnect.com\/verquvo\/coverage\/?safety_overlay&cid=PPC-accountype:MICROSOFT-campaign:Verquvo+HCP_2023+Generic_BRND_NA_ENGM_PHRS_TEXT_NA-searchterm:Vericiguat-adgroup:Generic+Core-keywordid:p76545871180&utm_source=bing&utm_medium=cpc&utm_campaign=Verquvo%20HCP_2023%20Generic_BRND_NA_ENGM_PHRS_TEXT_NA&utm_term=Vericiguat&utm_content=Generic%20Core&gclid=8f4f4acd541318362c972fd5148bf551&gclsrc=3p.ds&msclkid=8f4f4acd541318362c972fd5148bf551. Cited 30 Sep 2023."},{"issue":"19","key":"351_CR100","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1093\/eurheartj\/ehx032","volume":"38","author":"R D\u2019Souza","year":"2017","unstructured":"D\u2019Souza R, Ostro J, Shah PS, Silversides CK, Malinowski A, Murphy KE, et al. Anticoagulation for pregnant women with mechanical heart valves: a systematic review and meta-analysis. Eur Heart J. 2017;38(19):1509\u201316.","journal-title":"Eur Heart J"}],"container-title":["Cardiology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-024-00351-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40119-024-00351-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-024-00351-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T12:04:33Z","timestamp":1709121873000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40119-024-00351-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,10]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["351"],"URL":"https:\/\/doi.org\/10.1007\/s40119-024-00351-y","relation":{},"ISSN":["2193-8261","2193-6544"],"issn-type":[{"value":"2193-8261","type":"print"},{"value":"2193-6544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,10]]},"assertion":[{"value":"8 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Nosheen Reza reports speaking honoraria from Zoll, Inc. and consulting fees from Roche Diagnostics. Henrietta Afari and Megan Sheehan declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}